Oral VK2735
Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)
Viking Therapeutics · Phase 3 · Not yet recruiting · Enrollment 560
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.